Global Parkinson's Disease Treatment Market Size, Status and Forecast 2022
This report studies the global Parkinson's Disease Treatment market, analyzes and researches the Parkinson's Disease Treatment development status and forecast in United States, EU, Japan, China, India and Southeast Asia.
This report focuses on the top players in global market, like
This report focuses on the top players in global market, like
- Teva (Israel)
- Novartis AG (Switzerland)
- GSK (UK)
- AbbVie (US)
- Merck (US)
- Boehringer Ingelheim (Germany)
- Impax Laboratories (US)
- Lundbeck (Denmark)
- UCB (Belgium)
- Valeant Pharmaceuticals (Canada)
- Acadia (US)
- Sun Pharma (India)
- Wockhardt (India)
- Dr. Reddy’s (India)
- Intas (India)
- US WorldMeds (US)
- Zydus Cadila (India)
- Cipla (India)
- Strides (India)
- 1 A Pharma (India)
- Upsher-Smith (US)
- United States
- EU
- Japan
- China
- India
- Southeast Asia
- Levodopa/carbidopa
- Dopamine Receptor Agonists
- MAO-Inhibitors
- COMT-inhibitors
- Anticholinergics
- Other Drugs
- Hospital Pharmacies
- Retailer Pharmacies
- Online Pharmacies
Global Parkinson's Disease Treatment Market Size, Status and Forecast 2022
1 INDUSTRY OVERVIEW OF PARKINSON'S DISEASE TREATMENT
1.1 Parkinson's Disease Treatment Market Overview
1.1.1 Parkinson's Disease Treatment Product Scope
1.1.2 Market Status and Outlook
1.2 Global Parkinson's Disease Treatment Market Size and Analysis by Regions
1.2.1 United States
1.2.2 EU
1.2.3 Japan
1.2.4 China
1.2.5 India
1.2.6 Southeast Asia
1.3 Parkinson's Disease Treatment Market by Type
1.3.1 Levodopa/carbidopa
1.3.2 Dopamine Receptor Agonists
1.3.3 MAO-Inhibitors
1.3.4 COMT-inhibitors
1.3.5 Anticholinergics
1.3.6 Other Drugs
1.4 Parkinson's Disease Treatment Market by End Users/Application
1.4.1 Hospital Pharmacies
1.4.2 Retailer Pharmacies
1.4.3 Online Pharmacies
2 GLOBAL PARKINSON'S DISEASE TREATMENT COMPETITION ANALYSIS BY PLAYERS
2.1 Parkinson's Disease Treatment Market Size (Value) by Players (2016 and 2017)
2.2 Competitive Status and Trend
2.2.1 Market Concentration Rate
2.2.2 Product/Service Differences
2.2.3 New Entrants
2.2.4 The Technology Trends in Future
3 COMPANY (TOP PLAYERS) PROFILES
3.1 Teva (Israel)
3.1.1 Company Profile
3.1.2 Main Business/Business Overview
3.1.3 Products, Services and Solutions
3.1.4 Parkinson's Disease Treatment Revenue (Value) (2012-2017)
3.1.5 Recent Developments
3.2 Novartis AG (Switzerland)
3.2.1 Company Profile
3.2.2 Main Business/Business Overview
3.2.3 Products, Services and Solutions
3.2.4 Parkinson's Disease Treatment Revenue (Value) (2012-2017)
3.2.5 Recent Developments
3.3 GSK (UK)
3.3.1 Company Profile
3.3.2 Main Business/Business Overview
3.3.3 Products, Services and Solutions
3.3.4 Parkinson's Disease Treatment Revenue (Value) (2012-2017)
3.3.5 Recent Developments
3.4 AbbVie (US)
3.4.1 Company Profile
3.4.2 Main Business/Business Overview
3.4.3 Products, Services and Solutions
3.4.4 Parkinson's Disease Treatment Revenue (Value) (2012-2017)
3.4.5 Recent Developments
3.5 Merck (US)
3.5.1 Company Profile
3.5.2 Main Business/Business Overview
3.5.3 Products, Services and Solutions
3.5.4 Parkinson's Disease Treatment Revenue (Value) (2012-2017)
3.5.5 Recent Developments
3.6 Boehringer Ingelheim (Germany)
3.6.1 Company Profile
3.6.2 Main Business/Business Overview
3.6.3 Products, Services and Solutions
3.6.4 Parkinson's Disease Treatment Revenue (Value) (2012-2017)
3.6.5 Recent Developments
3.7 Impax Laboratories (US)
3.7.1 Company Profile
3.7.2 Main Business/Business Overview
3.7.3 Products, Services and Solutions
3.7.4 Parkinson's Disease Treatment Revenue (Value) (2012-2017)
3.7.5 Recent Developments
3.8 Lundbeck (Denmark)
3.8.1 Company Profile
3.8.2 Main Business/Business Overview
3.8.3 Products, Services and Solutions
3.8.4 Parkinson's Disease Treatment Revenue (Value) (2012-2017)
3.8.5 Recent Developments
3.9 UCB (Belgium)
3.9.1 Company Profile
3.9.2 Main Business/Business Overview
3.9.3 Products, Services and Solutions
3.9.4 Parkinson's Disease Treatment Revenue (Value) (2012-2017)
3.9.5 Recent Developments
3.10 Valeant Pharmaceuticals (Canada)
3.10.1 Company Profile
3.10.2 Main Business/Business Overview
3.10.3 Products, Services and Solutions
3.10.4 Parkinson's Disease Treatment Revenue (Value) (2012-2017)
3.10.5 Recent Developments
3.11 Acadia (US)
3.12 Sun Pharma (India)
3.13 Wockhardt (India)
3.14 Dr. Reddy’s (India)
3.15 Intas (India)
3.16 US WorldMeds (US)
3.17 Zydus Cadila (India)
3.18 Cipla (India)
3.19 Strides (India)
3.20 1 A Pharma (India)
3.21 Upsher-Smith (US)
4 GLOBAL PARKINSON'S DISEASE TREATMENT MARKET SIZE BY TYPE AND APPLICATION (2012-2017)
4.1 Global Parkinson's Disease Treatment Market Size by Type (2012-2017)
4.2 Global Parkinson's Disease Treatment Market Size by Application (2012-2017)
4.3 Potential Application of Parkinson's Disease Treatment in Future
4.4 Top Consumer/End Users of Parkinson's Disease Treatment
5 UNITED STATES PARKINSON'S DISEASE TREATMENT DEVELOPMENT STATUS AND OUTLOOK
5.1 United States Parkinson's Disease Treatment Market Size (2012-2017)
5.2 United States Parkinson's Disease Treatment Market Size and Market Share by Players (2016 and 2017)
6 EU PARKINSON'S DISEASE TREATMENT DEVELOPMENT STATUS AND OUTLOOK
6.1 EU Parkinson's Disease Treatment Market Size (2012-2017)
6.2 EU Parkinson's Disease Treatment Market Size and Market Share by Players (2016 and 2017)
7 JAPAN PARKINSON'S DISEASE TREATMENT DEVELOPMENT STATUS AND OUTLOOK
7.1 Japan Parkinson's Disease Treatment Market Size (2012-2017)
7.2 Japan Parkinson's Disease Treatment Market Size and Market Share by Players (2016 and 2017)
8 CHINA PARKINSON'S DISEASE TREATMENT DEVELOPMENT STATUS AND OUTLOOK
8.1 China Parkinson's Disease Treatment Market Size (2012-2017)
8.2 China Parkinson's Disease Treatment Market Size and Market Share by Players (2016 and 2017)
9 INDIA PARKINSON'S DISEASE TREATMENT DEVELOPMENT STATUS AND OUTLOOK
9.1 India Parkinson's Disease Treatment Market Size (2012-2017)
9.2 India Parkinson's Disease Treatment Market Size and Market Share by Players (2016 and 2017)
10 SOUTHEAST ASIA PARKINSON'S DISEASE TREATMENT DEVELOPMENT STATUS AND OUTLOOK
10.1 Southeast Asia Parkinson's Disease Treatment Market Size (2012-2017)
10.2 Southeast Asia Parkinson's Disease Treatment Market Size and Market Share by Players (2016 and 2017)
11 MARKET FORECAST BY REGIONS, TYPE AND APPLICATION (2017-2022)
11.1 Global Parkinson's Disease Treatment Market Size (Value) by Regions (2017-2022)
11.1.1 United States Parkinson's Disease Treatment Revenue and Growth Rate (2017-2022)
11.1.2 EU Parkinson's Disease Treatment Revenue and Growth Rate (2017-2022)
11.1.3 Japan Parkinson's Disease Treatment Revenue and Growth Rate (2017-2022)
11.1.4 China Parkinson's Disease Treatment Revenue and Growth Rate (2017-2022)
11.1.5 India Parkinson's Disease Treatment Revenue and Growth Rate (2017-2022)
11.1.6 Southeast Asia Parkinson's Disease Treatment Revenue and Growth Rate (2017-2022)
11.2 Global Parkinson's Disease Treatment Market Size (Value) by Type (2017-2022)
11.3 Global Parkinson's Disease Treatment Market Size by Application (2017-2022)
12 PARKINSON'S DISEASE TREATMENT MARKET DYNAMICS
12.1 Parkinson's Disease Treatment Market Opportunities
12.2 Parkinson's Disease Treatment Challenge and Risk
12.2.1 Competition from Opponents
12.2.2 Downside Risks of Economy
12.3 Parkinson's Disease Treatment Market Constraints and Threat
12.3.1 Threat from Substitute
12.3.2 Government Policy
12.3.3 Technology Risks
12.4 Parkinson's Disease Treatment Market Driving Force
12.4.1 Growing Demand from Emerging Markets
12.4.2 Potential Application
13 MARKET EFFECT FACTORS ANALYSIS
13.1 Technology Progress/Risk
13.1.1 Substitutes
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs Trend/Customer Preference
13.3 External Environmental Change
13.3.1 Economic Fluctuations
13.3.2 Other Risk Factors
14 RESEARCH FINDING/CONCLUSION
15 APPENDIX
Methodology
Analyst Introduction
Data Source
The report requires updating with new data and is sent in 2-3 business days after order is placed.
1 INDUSTRY OVERVIEW OF PARKINSON'S DISEASE TREATMENT
1.1 Parkinson's Disease Treatment Market Overview
1.1.1 Parkinson's Disease Treatment Product Scope
1.1.2 Market Status and Outlook
1.2 Global Parkinson's Disease Treatment Market Size and Analysis by Regions
1.2.1 United States
1.2.2 EU
1.2.3 Japan
1.2.4 China
1.2.5 India
1.2.6 Southeast Asia
1.3 Parkinson's Disease Treatment Market by Type
1.3.1 Levodopa/carbidopa
1.3.2 Dopamine Receptor Agonists
1.3.3 MAO-Inhibitors
1.3.4 COMT-inhibitors
1.3.5 Anticholinergics
1.3.6 Other Drugs
1.4 Parkinson's Disease Treatment Market by End Users/Application
1.4.1 Hospital Pharmacies
1.4.2 Retailer Pharmacies
1.4.3 Online Pharmacies
2 GLOBAL PARKINSON'S DISEASE TREATMENT COMPETITION ANALYSIS BY PLAYERS
2.1 Parkinson's Disease Treatment Market Size (Value) by Players (2016 and 2017)
2.2 Competitive Status and Trend
2.2.1 Market Concentration Rate
2.2.2 Product/Service Differences
2.2.3 New Entrants
2.2.4 The Technology Trends in Future
3 COMPANY (TOP PLAYERS) PROFILES
3.1 Teva (Israel)
3.1.1 Company Profile
3.1.2 Main Business/Business Overview
3.1.3 Products, Services and Solutions
3.1.4 Parkinson's Disease Treatment Revenue (Value) (2012-2017)
3.1.5 Recent Developments
3.2 Novartis AG (Switzerland)
3.2.1 Company Profile
3.2.2 Main Business/Business Overview
3.2.3 Products, Services and Solutions
3.2.4 Parkinson's Disease Treatment Revenue (Value) (2012-2017)
3.2.5 Recent Developments
3.3 GSK (UK)
3.3.1 Company Profile
3.3.2 Main Business/Business Overview
3.3.3 Products, Services and Solutions
3.3.4 Parkinson's Disease Treatment Revenue (Value) (2012-2017)
3.3.5 Recent Developments
3.4 AbbVie (US)
3.4.1 Company Profile
3.4.2 Main Business/Business Overview
3.4.3 Products, Services and Solutions
3.4.4 Parkinson's Disease Treatment Revenue (Value) (2012-2017)
3.4.5 Recent Developments
3.5 Merck (US)
3.5.1 Company Profile
3.5.2 Main Business/Business Overview
3.5.3 Products, Services and Solutions
3.5.4 Parkinson's Disease Treatment Revenue (Value) (2012-2017)
3.5.5 Recent Developments
3.6 Boehringer Ingelheim (Germany)
3.6.1 Company Profile
3.6.2 Main Business/Business Overview
3.6.3 Products, Services and Solutions
3.6.4 Parkinson's Disease Treatment Revenue (Value) (2012-2017)
3.6.5 Recent Developments
3.7 Impax Laboratories (US)
3.7.1 Company Profile
3.7.2 Main Business/Business Overview
3.7.3 Products, Services and Solutions
3.7.4 Parkinson's Disease Treatment Revenue (Value) (2012-2017)
3.7.5 Recent Developments
3.8 Lundbeck (Denmark)
3.8.1 Company Profile
3.8.2 Main Business/Business Overview
3.8.3 Products, Services and Solutions
3.8.4 Parkinson's Disease Treatment Revenue (Value) (2012-2017)
3.8.5 Recent Developments
3.9 UCB (Belgium)
3.9.1 Company Profile
3.9.2 Main Business/Business Overview
3.9.3 Products, Services and Solutions
3.9.4 Parkinson's Disease Treatment Revenue (Value) (2012-2017)
3.9.5 Recent Developments
3.10 Valeant Pharmaceuticals (Canada)
3.10.1 Company Profile
3.10.2 Main Business/Business Overview
3.10.3 Products, Services and Solutions
3.10.4 Parkinson's Disease Treatment Revenue (Value) (2012-2017)
3.10.5 Recent Developments
3.11 Acadia (US)
3.12 Sun Pharma (India)
3.13 Wockhardt (India)
3.14 Dr. Reddy’s (India)
3.15 Intas (India)
3.16 US WorldMeds (US)
3.17 Zydus Cadila (India)
3.18 Cipla (India)
3.19 Strides (India)
3.20 1 A Pharma (India)
3.21 Upsher-Smith (US)
4 GLOBAL PARKINSON'S DISEASE TREATMENT MARKET SIZE BY TYPE AND APPLICATION (2012-2017)
4.1 Global Parkinson's Disease Treatment Market Size by Type (2012-2017)
4.2 Global Parkinson's Disease Treatment Market Size by Application (2012-2017)
4.3 Potential Application of Parkinson's Disease Treatment in Future
4.4 Top Consumer/End Users of Parkinson's Disease Treatment
5 UNITED STATES PARKINSON'S DISEASE TREATMENT DEVELOPMENT STATUS AND OUTLOOK
5.1 United States Parkinson's Disease Treatment Market Size (2012-2017)
5.2 United States Parkinson's Disease Treatment Market Size and Market Share by Players (2016 and 2017)
6 EU PARKINSON'S DISEASE TREATMENT DEVELOPMENT STATUS AND OUTLOOK
6.1 EU Parkinson's Disease Treatment Market Size (2012-2017)
6.2 EU Parkinson's Disease Treatment Market Size and Market Share by Players (2016 and 2017)
7 JAPAN PARKINSON'S DISEASE TREATMENT DEVELOPMENT STATUS AND OUTLOOK
7.1 Japan Parkinson's Disease Treatment Market Size (2012-2017)
7.2 Japan Parkinson's Disease Treatment Market Size and Market Share by Players (2016 and 2017)
8 CHINA PARKINSON'S DISEASE TREATMENT DEVELOPMENT STATUS AND OUTLOOK
8.1 China Parkinson's Disease Treatment Market Size (2012-2017)
8.2 China Parkinson's Disease Treatment Market Size and Market Share by Players (2016 and 2017)
9 INDIA PARKINSON'S DISEASE TREATMENT DEVELOPMENT STATUS AND OUTLOOK
9.1 India Parkinson's Disease Treatment Market Size (2012-2017)
9.2 India Parkinson's Disease Treatment Market Size and Market Share by Players (2016 and 2017)
10 SOUTHEAST ASIA PARKINSON'S DISEASE TREATMENT DEVELOPMENT STATUS AND OUTLOOK
10.1 Southeast Asia Parkinson's Disease Treatment Market Size (2012-2017)
10.2 Southeast Asia Parkinson's Disease Treatment Market Size and Market Share by Players (2016 and 2017)
11 MARKET FORECAST BY REGIONS, TYPE AND APPLICATION (2017-2022)
11.1 Global Parkinson's Disease Treatment Market Size (Value) by Regions (2017-2022)
11.1.1 United States Parkinson's Disease Treatment Revenue and Growth Rate (2017-2022)
11.1.2 EU Parkinson's Disease Treatment Revenue and Growth Rate (2017-2022)
11.1.3 Japan Parkinson's Disease Treatment Revenue and Growth Rate (2017-2022)
11.1.4 China Parkinson's Disease Treatment Revenue and Growth Rate (2017-2022)
11.1.5 India Parkinson's Disease Treatment Revenue and Growth Rate (2017-2022)
11.1.6 Southeast Asia Parkinson's Disease Treatment Revenue and Growth Rate (2017-2022)
11.2 Global Parkinson's Disease Treatment Market Size (Value) by Type (2017-2022)
11.3 Global Parkinson's Disease Treatment Market Size by Application (2017-2022)
12 PARKINSON'S DISEASE TREATMENT MARKET DYNAMICS
12.1 Parkinson's Disease Treatment Market Opportunities
12.2 Parkinson's Disease Treatment Challenge and Risk
12.2.1 Competition from Opponents
12.2.2 Downside Risks of Economy
12.3 Parkinson's Disease Treatment Market Constraints and Threat
12.3.1 Threat from Substitute
12.3.2 Government Policy
12.3.3 Technology Risks
12.4 Parkinson's Disease Treatment Market Driving Force
12.4.1 Growing Demand from Emerging Markets
12.4.2 Potential Application
13 MARKET EFFECT FACTORS ANALYSIS
13.1 Technology Progress/Risk
13.1.1 Substitutes
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs Trend/Customer Preference
13.3 External Environmental Change
13.3.1 Economic Fluctuations
13.3.2 Other Risk Factors
14 RESEARCH FINDING/CONCLUSION
15 APPENDIX
Methodology
Analyst Introduction
Data Source
The report requires updating with new data and is sent in 2-3 business days after order is placed.
LIST OF TABLES AND FIGURES
Figure Parkinson's Disease Treatment Product Scope
Figure Global Parkinson's Disease Treatment Market Size (Million USD) (2012-2017)
Table Global Parkinson's Disease Treatment Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Global Parkinson's Disease Treatment Market Share by Regions in 2016
Figure United States Parkinson's Disease Treatment Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure EU Parkinson's Disease Treatment Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Japan Parkinson's Disease Treatment Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure China Parkinson's Disease Treatment Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure India Parkinson's Disease Treatment Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Southeast Asia Parkinson's Disease Treatment Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Global Parkinson's Disease Treatment Market Share by Type in 2016
Figure Levodopa/carbidopa Market Size (Million USD) and Growth Rate (2012-2017)
Figure Dopamine Receptor Agonists Market Size (Million USD) and Growth Rate (2012-2017)
Figure MAO-Inhibitors Market Size (Million USD) and Growth Rate (2012-2017)
Figure COMT-inhibitors Market Size (Million USD) and Growth Rate (2012-2017)
Figure Anticholinergics Market Size (Million USD) and Growth Rate (2012-2017)
Figure Other Drugs Market Size (Million USD) and Growth Rate (2012-2017)
Figure Global Parkinson's Disease Treatment Market Share by Application in 2016
Table Key Downstream Customer in Hospital Pharmacies
Figure Parkinson's Disease Treatment Market Size (Million USD) and Growth Rate in Hospital Pharmacies (2012-2017)
Table Key Downstream Customer in Retailer Pharmacies
Figure Parkinson's Disease Treatment Market Size (Million USD) and Growth Rate in Retailer Pharmacies (2012-2017)
Table Key Downstream Customer in Online Pharmacies
Figure Parkinson's Disease Treatment Market Size (Million USD) and Growth Rate in Online Pharmacies (2012-2017)
Table Parkinson's Disease Treatment Market Size (Million USD) by Players (2016 and 2017)
Figure Parkinson's Disease Treatment Market Size Share by Players in 2016
Figure Parkinson's Disease Treatment Market Size Share by Players in 2017
Table Teva (Israel) Basic Information List
Table Parkinson's Disease Treatment Business Revenue (Million USD) of Teva (Israel) (2012-2017)
Figure Teva (Israel) Parkinson's Disease Treatment Business Revenue Market Share in 2016
Table Novartis AG (Switzerland) Basic Information List
Table Parkinson's Disease Treatment Business Revenue (Million USD) of Novartis AG (Switzerland) (2012-2017)
Figure Novartis AG (Switzerland) Parkinson's Disease Treatment Business Revenue Market Share in 2016
Table GSK (UK) Basic Information List
Table Parkinson's Disease Treatment Business Revenue (Million USD) of GSK (UK) (2012-2017)
Figure GSK (UK) Parkinson's Disease Treatment Business Revenue Market Share in 2016
Table AbbVie (US) Basic Information List
Table Parkinson's Disease Treatment Business Revenue (Million USD) of AbbVie (US) (2012-2017)
Figure AbbVie (US) Parkinson's Disease Treatment Business Revenue Market Share in 2016
Table Merck (US) Basic Information List
Table Parkinson's Disease Treatment Business Revenue (Million USD) of Merck (US) (2012-2017)
Figure Merck (US) Parkinson's Disease Treatment Business Revenue Market Share in 2016
Table Boehringer Ingelheim (Germany) Basic Information List
Table Parkinson's Disease Treatment Business Revenue (Million USD) of Boehringer Ingelheim (Germany) (2012-2017)
Figure Boehringer Ingelheim (Germany) Parkinson's Disease Treatment Business Revenue Market Share in 2016
Table Impax Laboratories (US) Basic Information List
Table Parkinson's Disease Treatment Business Revenue (Million USD) of Impax Laboratories (US) (2012-2017)
Figure Impax Laboratories (US) Parkinson's Disease Treatment Business Revenue Market Share in 2016
Table Lundbeck (Denmark) Basic Information List
Table Parkinson's Disease Treatment Business Revenue (Million USD) of Lundbeck (Denmark) (2012-2017)
Figure Lundbeck (Denmark) Parkinson's Disease Treatment Business Revenue Market Share in 2016
Table UCB (Belgium) Basic Information List
Table Parkinson's Disease Treatment Business Revenue (Million USD) of UCB (Belgium) (2012-2017)
Figure UCB (Belgium) Parkinson's Disease Treatment Business Revenue Market Share in 2016
Table Valeant Pharmaceuticals (Canada) Basic Information List
Table Parkinson's Disease Treatment Business Revenue (Million USD) of Valeant Pharmaceuticals (Canada) (2012-2017)
Figure Valeant Pharmaceuticals (Canada) Parkinson's Disease Treatment Business Revenue Market Share in 2016
Table Acadia (US) Basic Information List
Table Parkinson's Disease Treatment Business Revenue (Million USD) of Acadia (US) (2012-2017)
Figure Acadia (US) Parkinson's Disease Treatment Business Revenue Market Share in 2016
Table Sun Pharma (India) Basic Information List
Table Parkinson's Disease Treatment Business Revenue (Million USD) of Sun Pharma (India) (2012-2017)
Figure Sun Pharma (India) Parkinson's Disease Treatment Business Revenue Market Share in 2016
Table Wockhardt (India) Basic Information List
Table Parkinson's Disease Treatment Business Revenue (Million USD) of Wockhardt (India) (2012-2017)
Figure Wockhardt (India) Parkinson's Disease Treatment Business Revenue Market Share in 2016
Table Dr. Reddy’s (India) Basic Information List
Table Parkinson's Disease Treatment Business Revenue (Million USD) of Dr. Reddy’s (India) (2012-2017)
Figure Dr. Reddy’s (India) Parkinson's Disease Treatment Business Revenue Market Share in 2016
Table Intas (India) Basic Information List
Table Parkinson's Disease Treatment Business Revenue (Million USD) of Intas (India) (2012-2017)
Figure Intas (India) Parkinson's Disease Treatment Business Revenue Market Share in 2016
Table US WorldMeds (US) Basic Information List
Table Parkinson's Disease Treatment Business Revenue (Million USD) of US WorldMeds (US) (2012-2017)
Figure US WorldMeds (US) Parkinson's Disease Treatment Business Revenue Market Share in 2016
Table Zydus Cadila (India) Basic Information List
Table Parkinson's Disease Treatment Business Revenue (Million USD) of Zydus Cadila (India) (2012-2017)
Figure Zydus Cadila (India) Parkinson's Disease Treatment Business Revenue Market Share in 2016
Table Cipla (India) Basic Information List
Table Parkinson's Disease Treatment Business Revenue (Million USD) of Cipla (India) (2012-2017)
Figure Cipla (India) Parkinson's Disease Treatment Business Revenue Market Share in 2016
Table Strides (India) Basic Information List
Table Parkinson's Disease Treatment Business Revenue (Million USD) of Strides (India) (2012-2017)
Figure Strides (India) Parkinson's Disease Treatment Business Revenue Market Share in 2016
Table 1 A Pharma (India) Basic Information List
Table Parkinson's Disease Treatment Business Revenue (Million USD) of 1 A Pharma (India) (2012-2017)
Figure 1 A Pharma (India) Parkinson's Disease Treatment Business Revenue Market Share in 2016
Table Upsher-Smith (US) Basic Information List
Table Parkinson's Disease Treatment Business Revenue (Million USD) of Upsher-Smith (US) (2012-2017)
Figure Upsher-Smith (US) Parkinson's Disease Treatment Business Revenue Market Share in 2016
Table Global Parkinson's Disease Treatment Market Size (Million USD) by Type (2012-2017)
Figure Global Parkinson's Disease Treatment Market Size Share by Type in 2012
Figure Global Parkinson's Disease Treatment Market Size Share by Type in 2013
Figure Global Parkinson's Disease Treatment Market Size Share by Type in 2014
Figure Global Parkinson's Disease Treatment Market Size Share by Type in 2015
Figure Global Parkinson's Disease Treatment Market Size Share by Type in 2016
Figure Global Parkinson's Disease Treatment Market Size Share by Type in 2017
Table Global Parkinson's Disease Treatment Market Size (Million USD) by Application (2012-2017)
Figure Global Parkinson's Disease Treatment Market Size (Million USD) by Application in 2012
Figure Global Parkinson's Disease Treatment Market Size (Million USD) by Application in 2013
Figure Global Parkinson's Disease Treatment Market Size (Million USD) by Application in 2014
Figure Global Parkinson's Disease Treatment Market Size (Million USD) by Application in 2015
Figure Global Parkinson's Disease Treatment Market Size (Million USD) by Application in 2016
Figure Global Parkinson's Disease Treatment Market Size (Million USD) by Application in 2017
Table Top Consumer/End Users of Parkinson's Disease Treatment
Figure United States Parkinson's Disease Treatment Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table United States Parkinson's Disease Treatment Market Size (Million USD) by Players (2012-2017)
Figure United States Parkinson's Disease Treatment Market Size Share by Players in 2016
Figure United States Parkinson's Disease Treatment Market Size Share by Players in 2017
Figure EU Parkinson's Disease Treatment Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table EU Parkinson's Disease Treatment Market Size (Million USD) by Players (2012-2017)
Figure EU Parkinson's Disease Treatment Market Size Share by Players in 2016
Figure EU Parkinson's Disease Treatment Market Size Share by Players in 2017
Figure Japan Parkinson's Disease Treatment Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table Japan Parkinson's Disease Treatment Market Size (Million USD) by Players (2012-2017)
Figure Japan Parkinson's Disease Treatment Market Size Share by Players in 2016
Figure Japan Parkinson's Disease Treatment Market Size Share by Players in 2017
Figure China Parkinson's Disease Treatment Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table China Parkinson's Disease Treatment Market Size (Million USD) by Players (2012-2017)
Figure China Parkinson's Disease Treatment Market Size Share by Players in 2016
Figure China Parkinson's Disease Treatment Market Size Share by Players in 2017
Figure India Parkinson's Disease Treatment Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table India Parkinson's Disease Treatment Market Size (Million USD) by Players (2012-2017)
Figure India Parkinson's Disease Treatment Market Size Share by Players in 2016
Figure India Parkinson's Disease Treatment Market Size Share by Players in 2017
Figure Southeast Asia Parkinson's Disease Treatment Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table Southeast Asia Parkinson's Disease Treatment Market Size (Million USD) by Players (2012-2017)
Figure Southeast Asia Parkinson's Disease Treatment Market Size Share by Players in 2016
Figure Southeast Asia Parkinson's Disease Treatment Market Size Share by Players in 2017
Figure Global Parkinson's Disease Treatment Market Size (Million USD) by Regions (2017-2022)
Table Global Parkinson's Disease Treatment Market Size (Million USD) by Regions (2017-2022)
Figure Global Parkinson's Disease Treatment Market Size Share by Regions in 2017
Figure Global Parkinson's Disease Treatment Market Size Share by Regions in 2022
Figure United States Parkinson's Disease Treatment Revenue (Million USD) and Growth Rate (2017-2022)
Figure EU Parkinson's Disease Treatment Revenue (Million USD) and Growth Rate (2017-2022)
Figure Japan Parkinson's Disease Treatment Revenue (Million USD) and Growth Rate (2017-2022)
Figure China Parkinson's Disease Treatment Revenue (Million USD) and Growth Rate (2017-2022)
Figure India Parkinson's Disease Treatment Revenue (Million USD) and Growth Rate (2017-2022)
Figure Southeast Asia Parkinson's Disease Treatment Revenue (Million USD) and Growth Rate (2017-2022)
Table Global Parkinson's Disease Treatment Market Size (Million USD) by Type (2017-2022)
Figure Global Parkinson's Disease Treatment Market Size Share by Type in 2017
Figure Global Parkinson's Disease Treatment Market Size Share by Type in 2022
Table Global Parkinson's Disease Treatment Market Size (Million USD) by Application (2017-2022)
Figure Global Parkinson's Disease Treatment Market Size (Million USD) by Application in 2017
Figure Global Parkinson's Disease Treatment Market Size (Million USD) by Application in 2022
Figure Parkinson's Disease Treatment Product Scope
Figure Global Parkinson's Disease Treatment Market Size (Million USD) (2012-2017)
Table Global Parkinson's Disease Treatment Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Global Parkinson's Disease Treatment Market Share by Regions in 2016
Figure United States Parkinson's Disease Treatment Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure EU Parkinson's Disease Treatment Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Japan Parkinson's Disease Treatment Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure China Parkinson's Disease Treatment Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure India Parkinson's Disease Treatment Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Southeast Asia Parkinson's Disease Treatment Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Global Parkinson's Disease Treatment Market Share by Type in 2016
Figure Levodopa/carbidopa Market Size (Million USD) and Growth Rate (2012-2017)
Figure Dopamine Receptor Agonists Market Size (Million USD) and Growth Rate (2012-2017)
Figure MAO-Inhibitors Market Size (Million USD) and Growth Rate (2012-2017)
Figure COMT-inhibitors Market Size (Million USD) and Growth Rate (2012-2017)
Figure Anticholinergics Market Size (Million USD) and Growth Rate (2012-2017)
Figure Other Drugs Market Size (Million USD) and Growth Rate (2012-2017)
Figure Global Parkinson's Disease Treatment Market Share by Application in 2016
Table Key Downstream Customer in Hospital Pharmacies
Figure Parkinson's Disease Treatment Market Size (Million USD) and Growth Rate in Hospital Pharmacies (2012-2017)
Table Key Downstream Customer in Retailer Pharmacies
Figure Parkinson's Disease Treatment Market Size (Million USD) and Growth Rate in Retailer Pharmacies (2012-2017)
Table Key Downstream Customer in Online Pharmacies
Figure Parkinson's Disease Treatment Market Size (Million USD) and Growth Rate in Online Pharmacies (2012-2017)
Table Parkinson's Disease Treatment Market Size (Million USD) by Players (2016 and 2017)
Figure Parkinson's Disease Treatment Market Size Share by Players in 2016
Figure Parkinson's Disease Treatment Market Size Share by Players in 2017
Table Teva (Israel) Basic Information List
Table Parkinson's Disease Treatment Business Revenue (Million USD) of Teva (Israel) (2012-2017)
Figure Teva (Israel) Parkinson's Disease Treatment Business Revenue Market Share in 2016
Table Novartis AG (Switzerland) Basic Information List
Table Parkinson's Disease Treatment Business Revenue (Million USD) of Novartis AG (Switzerland) (2012-2017)
Figure Novartis AG (Switzerland) Parkinson's Disease Treatment Business Revenue Market Share in 2016
Table GSK (UK) Basic Information List
Table Parkinson's Disease Treatment Business Revenue (Million USD) of GSK (UK) (2012-2017)
Figure GSK (UK) Parkinson's Disease Treatment Business Revenue Market Share in 2016
Table AbbVie (US) Basic Information List
Table Parkinson's Disease Treatment Business Revenue (Million USD) of AbbVie (US) (2012-2017)
Figure AbbVie (US) Parkinson's Disease Treatment Business Revenue Market Share in 2016
Table Merck (US) Basic Information List
Table Parkinson's Disease Treatment Business Revenue (Million USD) of Merck (US) (2012-2017)
Figure Merck (US) Parkinson's Disease Treatment Business Revenue Market Share in 2016
Table Boehringer Ingelheim (Germany) Basic Information List
Table Parkinson's Disease Treatment Business Revenue (Million USD) of Boehringer Ingelheim (Germany) (2012-2017)
Figure Boehringer Ingelheim (Germany) Parkinson's Disease Treatment Business Revenue Market Share in 2016
Table Impax Laboratories (US) Basic Information List
Table Parkinson's Disease Treatment Business Revenue (Million USD) of Impax Laboratories (US) (2012-2017)
Figure Impax Laboratories (US) Parkinson's Disease Treatment Business Revenue Market Share in 2016
Table Lundbeck (Denmark) Basic Information List
Table Parkinson's Disease Treatment Business Revenue (Million USD) of Lundbeck (Denmark) (2012-2017)
Figure Lundbeck (Denmark) Parkinson's Disease Treatment Business Revenue Market Share in 2016
Table UCB (Belgium) Basic Information List
Table Parkinson's Disease Treatment Business Revenue (Million USD) of UCB (Belgium) (2012-2017)
Figure UCB (Belgium) Parkinson's Disease Treatment Business Revenue Market Share in 2016
Table Valeant Pharmaceuticals (Canada) Basic Information List
Table Parkinson's Disease Treatment Business Revenue (Million USD) of Valeant Pharmaceuticals (Canada) (2012-2017)
Figure Valeant Pharmaceuticals (Canada) Parkinson's Disease Treatment Business Revenue Market Share in 2016
Table Acadia (US) Basic Information List
Table Parkinson's Disease Treatment Business Revenue (Million USD) of Acadia (US) (2012-2017)
Figure Acadia (US) Parkinson's Disease Treatment Business Revenue Market Share in 2016
Table Sun Pharma (India) Basic Information List
Table Parkinson's Disease Treatment Business Revenue (Million USD) of Sun Pharma (India) (2012-2017)
Figure Sun Pharma (India) Parkinson's Disease Treatment Business Revenue Market Share in 2016
Table Wockhardt (India) Basic Information List
Table Parkinson's Disease Treatment Business Revenue (Million USD) of Wockhardt (India) (2012-2017)
Figure Wockhardt (India) Parkinson's Disease Treatment Business Revenue Market Share in 2016
Table Dr. Reddy’s (India) Basic Information List
Table Parkinson's Disease Treatment Business Revenue (Million USD) of Dr. Reddy’s (India) (2012-2017)
Figure Dr. Reddy’s (India) Parkinson's Disease Treatment Business Revenue Market Share in 2016
Table Intas (India) Basic Information List
Table Parkinson's Disease Treatment Business Revenue (Million USD) of Intas (India) (2012-2017)
Figure Intas (India) Parkinson's Disease Treatment Business Revenue Market Share in 2016
Table US WorldMeds (US) Basic Information List
Table Parkinson's Disease Treatment Business Revenue (Million USD) of US WorldMeds (US) (2012-2017)
Figure US WorldMeds (US) Parkinson's Disease Treatment Business Revenue Market Share in 2016
Table Zydus Cadila (India) Basic Information List
Table Parkinson's Disease Treatment Business Revenue (Million USD) of Zydus Cadila (India) (2012-2017)
Figure Zydus Cadila (India) Parkinson's Disease Treatment Business Revenue Market Share in 2016
Table Cipla (India) Basic Information List
Table Parkinson's Disease Treatment Business Revenue (Million USD) of Cipla (India) (2012-2017)
Figure Cipla (India) Parkinson's Disease Treatment Business Revenue Market Share in 2016
Table Strides (India) Basic Information List
Table Parkinson's Disease Treatment Business Revenue (Million USD) of Strides (India) (2012-2017)
Figure Strides (India) Parkinson's Disease Treatment Business Revenue Market Share in 2016
Table 1 A Pharma (India) Basic Information List
Table Parkinson's Disease Treatment Business Revenue (Million USD) of 1 A Pharma (India) (2012-2017)
Figure 1 A Pharma (India) Parkinson's Disease Treatment Business Revenue Market Share in 2016
Table Upsher-Smith (US) Basic Information List
Table Parkinson's Disease Treatment Business Revenue (Million USD) of Upsher-Smith (US) (2012-2017)
Figure Upsher-Smith (US) Parkinson's Disease Treatment Business Revenue Market Share in 2016
Table Global Parkinson's Disease Treatment Market Size (Million USD) by Type (2012-2017)
Figure Global Parkinson's Disease Treatment Market Size Share by Type in 2012
Figure Global Parkinson's Disease Treatment Market Size Share by Type in 2013
Figure Global Parkinson's Disease Treatment Market Size Share by Type in 2014
Figure Global Parkinson's Disease Treatment Market Size Share by Type in 2015
Figure Global Parkinson's Disease Treatment Market Size Share by Type in 2016
Figure Global Parkinson's Disease Treatment Market Size Share by Type in 2017
Table Global Parkinson's Disease Treatment Market Size (Million USD) by Application (2012-2017)
Figure Global Parkinson's Disease Treatment Market Size (Million USD) by Application in 2012
Figure Global Parkinson's Disease Treatment Market Size (Million USD) by Application in 2013
Figure Global Parkinson's Disease Treatment Market Size (Million USD) by Application in 2014
Figure Global Parkinson's Disease Treatment Market Size (Million USD) by Application in 2015
Figure Global Parkinson's Disease Treatment Market Size (Million USD) by Application in 2016
Figure Global Parkinson's Disease Treatment Market Size (Million USD) by Application in 2017
Table Top Consumer/End Users of Parkinson's Disease Treatment
Figure United States Parkinson's Disease Treatment Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table United States Parkinson's Disease Treatment Market Size (Million USD) by Players (2012-2017)
Figure United States Parkinson's Disease Treatment Market Size Share by Players in 2016
Figure United States Parkinson's Disease Treatment Market Size Share by Players in 2017
Figure EU Parkinson's Disease Treatment Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table EU Parkinson's Disease Treatment Market Size (Million USD) by Players (2012-2017)
Figure EU Parkinson's Disease Treatment Market Size Share by Players in 2016
Figure EU Parkinson's Disease Treatment Market Size Share by Players in 2017
Figure Japan Parkinson's Disease Treatment Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table Japan Parkinson's Disease Treatment Market Size (Million USD) by Players (2012-2017)
Figure Japan Parkinson's Disease Treatment Market Size Share by Players in 2016
Figure Japan Parkinson's Disease Treatment Market Size Share by Players in 2017
Figure China Parkinson's Disease Treatment Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table China Parkinson's Disease Treatment Market Size (Million USD) by Players (2012-2017)
Figure China Parkinson's Disease Treatment Market Size Share by Players in 2016
Figure China Parkinson's Disease Treatment Market Size Share by Players in 2017
Figure India Parkinson's Disease Treatment Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table India Parkinson's Disease Treatment Market Size (Million USD) by Players (2012-2017)
Figure India Parkinson's Disease Treatment Market Size Share by Players in 2016
Figure India Parkinson's Disease Treatment Market Size Share by Players in 2017
Figure Southeast Asia Parkinson's Disease Treatment Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table Southeast Asia Parkinson's Disease Treatment Market Size (Million USD) by Players (2012-2017)
Figure Southeast Asia Parkinson's Disease Treatment Market Size Share by Players in 2016
Figure Southeast Asia Parkinson's Disease Treatment Market Size Share by Players in 2017
Figure Global Parkinson's Disease Treatment Market Size (Million USD) by Regions (2017-2022)
Table Global Parkinson's Disease Treatment Market Size (Million USD) by Regions (2017-2022)
Figure Global Parkinson's Disease Treatment Market Size Share by Regions in 2017
Figure Global Parkinson's Disease Treatment Market Size Share by Regions in 2022
Figure United States Parkinson's Disease Treatment Revenue (Million USD) and Growth Rate (2017-2022)
Figure EU Parkinson's Disease Treatment Revenue (Million USD) and Growth Rate (2017-2022)
Figure Japan Parkinson's Disease Treatment Revenue (Million USD) and Growth Rate (2017-2022)
Figure China Parkinson's Disease Treatment Revenue (Million USD) and Growth Rate (2017-2022)
Figure India Parkinson's Disease Treatment Revenue (Million USD) and Growth Rate (2017-2022)
Figure Southeast Asia Parkinson's Disease Treatment Revenue (Million USD) and Growth Rate (2017-2022)
Table Global Parkinson's Disease Treatment Market Size (Million USD) by Type (2017-2022)
Figure Global Parkinson's Disease Treatment Market Size Share by Type in 2017
Figure Global Parkinson's Disease Treatment Market Size Share by Type in 2022
Table Global Parkinson's Disease Treatment Market Size (Million USD) by Application (2017-2022)
Figure Global Parkinson's Disease Treatment Market Size (Million USD) by Application in 2017
Figure Global Parkinson's Disease Treatment Market Size (Million USD) by Application in 2022
